Finance

Lists
NUS:NYSE
NU Skin Enterprises Inc
4,74 US$
-0,63%
(-0,030) 1D
4,77 US$
+0,63% (+0,030)
After hours
Closed: 9 ოქტ, 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUS...
Open
4,77 US$
High
4,86 US$
Low
4,73 US$
Mkt. cap
230,73 მლნ.
Avg. vol.
530,72 ათ.
Volume
327,30 ათ.
Dividend
5,06%
Quarterly dividend
0,06 US$
Ex-dividend date
28 აგვ. 2026
52-wk high
11,67 US$
52-wk low
4,44 US$
EPS
-4,48 US$
Beta
0,91
Shares outstanding
48,68 მლნ.
No. of employees
3 ათ.
Open
4,77 US$
High
4,86 US$
Low
4,73 US$
Mkt. cap
230,73 მლნ.
Avg. vol.
530,72 ათ.
Volume
327,30 ათ.
Dividend
5,06%
Quarterly dividend
0,06 US$
Ex-dividend date
28 აგვ. 2026
52-wk high
11,67 US$
52-wk low
4,44 US$
EPS
-4,48 US$
Beta
0,91
Shares outstanding
48,68 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Profile
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. The company was founded in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund. Wikipedia
About NU Skin Enterprises Inc
CEOრაიან ნაპიერსკი
Employees2,8 ათ.
Founded1984
Headquartersპროვო, იუტა, ამერიკის შეერთებული შტატები
SectorPersonal care products
Websitenuskin.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
10 აგვ. 2026
Fiscal period
Q2 2026
0,20 US$ / 0,20 US$
0,00%miss
Revenue / Est. (USD)
320,11 მლნ. / 345,20 მლნ.
-7,27%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
364,21 მლნ.
370,32 მლნ.
320,61 მლნ.
320,11 მლნ.
Cost of goods sold
107,49 მლნ.
108,34 მლნ.
106,14 მლნ.
101,79 მლნ.
Cost of revenue
107,49 მლნ.
108,34 მლნ.
106,14 მლნ.
101,79 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
235,08 მლნ.
238,74 მლნ.
208,60 მლნ.
198,77 მლნ.
Operating expense
235,08 მლნ.
238,74 მლნ.
208,60 მლნ.
198,77 მლნ.
Total operating expenses
342,57 მლნ.
347,08 მლნ.
314,74 მლნ.
300,56 მლნ.
Operating income
21,64 მლნ.
23,24 მლნ.
5,86 მლნ.
19,56 მლნ.
Other non operating income
26,57 მლნ.
-29,14 მლნ.
2,82 მლნ.
-534,00 ათ.
EBT including unusual items
15,99 მლნ.
18,19 მლნ.
2,60 მლნ.
-63,18 მლნ.
EBT excluding unusual items
44,07 მლნ.
-9,89 მლნ.
4,44 მლნ.
15,70 მლნ.
Income tax expense
-1,08 მლნ.
3,70 მლნ.
763,00 ათ.
186,62 მლნ.
Effective tax rate
-6,78%
20,34%
29,36%
-295,41%
Other operating expenses
-
-
-
-
Net income
17,08 მლნ.
14,49 მლნ.
1,84 მლნ.
-249,80 მლნ.
Net profit margin
4,69%
3,91%
0,57%
-78,03%
Earnings per share
0,34
0,29
0,14
0,20
Interest and investment income
-
-
-
-
Interest expense
-4,14 მლნ.
-3,99 მლნ.
-4,25 მლნ.
-3,32 მლნ.
Net interest expenses
-4,14 მლნ.
-3,99 მლნ.
-4,25 მლნ.
-3,32 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
33,73 მლნ.
36,16 მლნ.
18,21 მლნ.
32,21 მლნ.
Gain or loss from assets sale
243,00 ათ.
-11,00 ათ.
303,00 ათ.
-10,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები